University Medical Centre Utrecht
Zeist, Netherlands
Femke van Wijk is a Professor in Tissue Immunology at the Center for Translational Immunology at the University Medical Centre Utrecht (UMCU) in the Netherlands. Her team aims to elucidate peripheral and local T cell responses in health and inflammation and to translate these insights into tools for (pre-clinical) disease monitoring and therapeutic targeting in chronic inflammatory diseases. She takes a disease- and age-overarching approach to decipher common and specific pathogenic processes underlying different inflammatory conditions and one of her specific interests is early imprinting of disease. Diseases her group is working on include atopic dermatitis, inflammatory bowel disease, juvenile idiopathic arthritis, and juvenile dermatomyositis. Since 2022, Dr. van Wijk has been the manager of research for the division of pediatrics at the Wilhelmina Children’s Hospital. In this role, Dr. van Wijk is responsible for research policy and talent management within the division and is committed to empowering the next generation of clinical scientists. Since 2020, Dr. van Wijk has also served as the scientific director of the Federation of Clinical Immunology Societies (FOCIS) Center of Excellence (FCE).
In 2023 she received the Athena award for outstanding female researchers from the Dutch Research Council.
Juvenile Dermatomyositis Vasculopathy: Emerging Biomarkers
Sunday, October 26, 2025
3:00 PM – 3:30 PM Central Time
Disclosure(s): AbbVie/Abbott: Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Grant/Research Support (Ongoing); Galapagos: Grant/Research Support (Ongoing); Leo Pharma: Grant/Research Support (Ongoing); Sanofi/Regeneron: Grant/Research Support (Ongoing); Takeda: Grant/Research Support (Ongoing)
